The 2025 Nobel Prize in Chemistry has been awarded for a versatile technology that can be used for an astonishing variety of purposes, from environmental remediation to drug delivery and energy ...

DURHAM, N.C., May 14, 2025--(BUSINESS WIRE)--Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene ...

This week's episode features two Nobel Prize announcements, a potential gene therapy for Huntington’s, and a partnership to develop gene editing therapies for rare diseases.

The Chronic Obstructive Pulmonary Disease Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase.

Balanced approach: Participants can chose from a wide range of classes. Words like ‘organic’, ‘eco-friendly’, and ‘sustainable’ aren’t just hippy conver­sation starters anymore; they are the way ...